Literature DB >> 25933497

ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model.

Takuji Suzuki1, Takeshi Muramatsu2, Kousuke Morioka2, Toshinao Goda2, Kazuki Mochizuki3.   

Abstract

OBJECTIVE: Although the expression of hepatic lipogenic genes is enhanced in insulin resistance, the underlying mechanism is unclear. To reveal the details, the aim of this study was to investigate whether the expression of hepatic lipogenic genes are mediated by epigenetic regulation and specific transcription factors in an insulin resistance model of rats.
METHODS: Using a rat model of insulin resistance (SHR/NDmc-cp), we investigated the relationship between hepatic expression of the lipogenic gene fatty-acid synthase (Fasn), binding of the transcription factor carbohydrate-responsive element-binding protein (ChREBP) to the Fasn gene, and histone modifications in the region of the Fasn gene by real-time reverse transcriptase polymerase chain reaction, immunoblotting, and chromatin immunoprecipitation assay.
RESULTS: Compared with control rats, Fasn mRNA expression and protein levels were higher in the livers of SHR/NDmc-cp rats, as were protein expression levels and Fasn binding of ChREBP and RNA polymerase II. Moreover, compared with the livers of control rats, levels of mono-methylated histone H3 lysine (K) 4 and acetylated histone H4 were higher in the promoter/enhancer region of the Fasn gene in the livers of SHR/NDmc-cp rats. Levels of trimethylated histone H3K4 and acetylated histone H3 were higher in the transcribed region.
CONCLUSION: The results of this study indicate that expression of the Fasn gene in the livers of insulin-resistant rats is associated with increased H3K4 methylation, increased histone H3 acetylation, and increased H4 acetylation, and also, binding levels of ChREBP to promoter/enhancer region of Fasn gene is involved in the Fasn gene expression caused by hyperglycemia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ChREBP; Histone modifications; Insulin resistance; Lipogenesis; Liver

Mesh:

Substances:

Year:  2015        PMID: 25933497     DOI: 10.1016/j.nut.2015.01.005

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

1.  FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice.

Authors:  Timothy D Rohrbach; Amon Asgharpour; Melissa A Maczis; David Montefusco; L Ashley Cowart; Pierre Bedossa; Arun J Sanyal; Sarah Spiegel
Journal:  J Lipid Res       Date:  2019-05-20       Impact factor: 5.922

2.  Metabolic and genomic adaptations to winter fattening in a primate species, the grey mouse lemur (Microcebus murinus).

Authors:  J Terrien; M Gaudubois; D Champeval; V Zaninotto; L Roger; J F Riou; F Aujard
Journal:  Int J Obes (Lond)       Date:  2017-08-14       Impact factor: 5.095

3.  Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice.

Authors:  Huabo Wang; James M Dolezal; Sucheta Kulkarni; Jie Lu; Jordan Mandel; Laura E Jackson; Frances Alencastro; Andrew W Duncan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2018-08-07       Impact factor: 5.157

4.  Effects of H3 and H4 histones acetylation and bindings of CREB binding protein and p300 at the promoter on hepatic expression of gamma-glutamyltransferase gene in a streptozotocin-induced moderate hypoinsulinemic rat model.

Authors:  T Tanaka; T Mizuno; T Nakagawa; T Hayakawa; M Shimada
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

Review 5.  The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease.

Authors:  Grace Park; Sunhee Jung; Kathryn E Wellen; Cholsoon Jang
Journal:  Exp Mol Med       Date:  2021-05-20       Impact factor: 8.718

6.  Prenatal caloric restriction alters lipid metabolism but not hepatic Fasn gene expression and methylation profiles in rats.

Authors:  Joanna Nowacka-Woszuk; Zofia E Madeja; Agata Chmurzynska
Journal:  BMC Genet       Date:  2017-08-15       Impact factor: 2.797

7.  Plasticity of histone modifications around Cidea and Cidec genes with secondary bile in the amelioration of developmentally-programmed hepatic steatosis.

Authors:  Jeenat Ferdous Urmi; Hiroaki Itoh; Keiko Muramatsu-Kato; Yukiko Kohmura-Kobayashi; Natsuyo Hariya; Divyanu Jain; Naoaki Tamura; Toshiyuki Uchida; Kazunao Suzuki; Yoshihiro Ogawa; Nobuaki Shiraki; Kazuki Mochizuki; Takeo Kubota; Naohiro Kanayama
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

8.  Antihypertensive activity of oleanolic acid is mediated via downregulation of secretory phospholipase A2 and fatty acid synthase in spontaneously hypertensive rats.

Authors:  Shiming Zhang; Yuecheng Liu; Xiaoming Wang; Zhenhua Tian; Dongmei Qi; Yunlun Li; Haiqiang Jiang
Journal:  Int J Mol Med       Date:  2020-09-30       Impact factor: 4.101

Review 9.  Regulation of Carbohydrate-Responsive Metabolic Genes by Histone Acetylation and the Acetylated Histone Reader BRD4 in the Gene Body Region.

Authors:  Kazuki Mochizuki; Shiori Ishiyama; Natsuyo Hariya; Toshinao Goda
Journal:  Front Mol Biosci       Date:  2021-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.